Companies:
49,730
Total Market Cap:
135832603849869.88
ReShape Lifesciences
NASDAQ: RSLS
Healthcare
Medical Devices
Global Rank
#42491
Country Rank
#5236
Market Cap
6.25 M
Price
2.62
Change (%)
2.34%
Volume
165,322
ReShape Lifesciences's latest marketcap:
6.25 M
As of 06/25/2025, ReShape Lifesciences's market capitalization has reached $6.25 M. According to our data, ReShape Lifesciences is the 42491th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 6.25 M |
| Revenue (ttm) | 7.18 M |
| Net Income (ttm) | -3,463,000 |
| Shares Out | 2.39 M |
| EPS (ttm) | -96.22 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/13/2025 |
Market Cap Chart
Data Updated: 06/25/2025
ReShape Lifesciences's yearly market capitalization.
ReShape Lifesciences has seen its market value drop from $19.82 M to $6.25 M since 2020, representing a total decrease of 68.46% and an annual compound decline rate (CAGR) of 22.69%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/25/2025 | $6.25 M | 91.42% | 42491 |
| 12/31/2024 | $3.18 M | -31.25% | 42202 |
| 12/29/2023 | $4.62 M | 42.07% | 39860 |
| 12/30/2022 | $3.25 M | -88.83% | 39351 |
| 12/31/2021 | $29.13 M | 46.99% | 30775 |
| 12/31/2020 | $19.82 M | 29544 |
Company Profile
ReShape Lifesciences was founded in 2002 in United States.
The company went public on 11/15/2007
on the Nasdaq Stock Market.
With 18 employees, it focuses on Healthcare and aims to drive innovation in Medical Devices.
Frequently Asked Questions
-
What is ReShape Lifesciences's (RSLS) current market cap?As of 06/25/2025, ReShape Lifesciences (including the parent company, if applicable) has an estimated market capitalization of $6.25 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ReShape Lifesciences (RSLS) rank globally by market cap?ReShape Lifesciences global market capitalization ranking is approximately 42491 as of 06/25/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.